Who invested in Ayala Pharmaceuticals?
Ayala Pharmaceuticals's investors include Novartis, Redmile Group, aMoon, SBI JI Innovation Fund and Harel Insurance & Finance Group, and 1 more on record.
United States · Funded startup
2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$55Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEs
From the SEC filings it signed: 5 on the team.
On the board, as filediBridget A. MartellMurray A. GoldbergPini A. OrbachRobert A. SpiegelRoni A. AppelVered A. Bisker-LeibYuval A. Cabilly
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Ayala Pharmaceuticals's investors include Novartis, Redmile Group, aMoon, SBI JI Innovation Fund and Harel Insurance & Finance Group, and 1 more on record.
Ayala Pharmaceuticals has raised $55M across 2 rounds since 2019.
Ayala Pharmaceuticals's most recent round was an Undisclosed round of $25M in Feb 2021.
Ayala Pharmaceuticals's largest round on record is $30M (Series B), in May 2019, led by Novartis.
Ayala Pharmaceuticals's first round on record, in May 2019, was backed by Novartis, aMoon and SBI JI Innovation Fund and 2 others.
Ayala Pharmaceuticals's latest named round is an Undisclosed round, in Feb 2021.
Ayala Pharmaceuticals is based in the United States.
Novartis led the Series B in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.